6505--Famciclovir Tablets

SOL #: 36E79726R0017Solicitation

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
NAC PHARMACEUTICALS (36E797)
HINES, IL, 60141, United States

Place of Performance

Place of performance not available

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 5, 2026
2
Last Updated
Mar 16, 2026
3
Submission Deadline
Mar 30, 2026, 7:30 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), specifically the NAC PHARMACEUTICALS (36E797) office, is soliciting proposals for Famciclovir Tablets (125mg, 250mg, and 500mg) in 30-tablet bottles. This is an unrestricted acquisition for a Firm Fixed Price, Indefinite-Delivery Requirements contract to establish national contract prices for distribution through VA and DoD Pharmaceutical Prime Vendor Programs. Proposals are due March 30, 2026.

Scope of Work

The successful contractor will supply Famciclovir tablets in specified strengths and package sizes. Key requirements include:

  • Providing an uninterrupted source of supply.
  • Using a unique 11-digit National Drug Code (NDC) for each offered drug.
  • Ensuring products meet FDA requirements and are manufactured in FDA cGMP acceptable facilities.
  • Packaging must comply with specified requirements, including safety caps, compatibility with automated dispensing units, and bar code labeling at the unit-of-use package level.
  • Compliance with Drug Supply Chain Security Act (DSCSA) requirements is mandatory.

Contract Details

  • Type: Firm Fixed Price, Indefinite-Delivery Requirements contract.
  • Period of Performance: Includes an Implementation Period, a one-year Base Ordering Period, and four pre-priced one-year option periods.
  • Distribution: Through the VA’s and DoD’s respective Pharmaceutical Prime Vendor Programs.
  • Estimated Quantities: Annual requirements are provided for VA, DoD, Bureau of Prisons (BOP), and Indian Health Service (IHS). For example, estimated annual requirements include 1,012 bottles of 125mg, 10,522 bottles of 250mg, and 13,642 bottles of 500mg Famciclovir tablets (30 count).

Submission & Evaluation

  • Submission: Proposals must be submitted via email to Richard.Mahario@va.gov and Nicholas.McGregor@va.gov, including a scanned copy of the signed SF-1449. Offerors must include pricing for the base year and all four option years for all line items.
  • Evaluation: Award will be based on the Lowest Price Technically Acceptable (LPTA) offer. Technical acceptability includes meeting product descriptions, unique NDC, FDA approval, and cGMP compliance.
  • Pricing: Must include a 0.5% Cost Recovery Fee.
  • Deadline: Offerors should submit proposals well before the deadline of March 30, 2026, and confirm receipt.

Eligibility & Notes

  • Set-Aside: This is an unrestricted acquisition.
  • Subcontracting: Other than small business concerns may be required to submit a subcontracting plan for contracts over $900,000.
  • Manufacturer Requirements: Offerors not manufacturing the items must submit a Letter of Commitment from the manufacturer.
  • VA Agreements: Offerors of covered drugs must have a Master Agreement (MA) and Pharmaceutical Pricing Agreement (PPA) in place with the VA.
  • NAICS Code: 325412.

People

Points of Contact

Richard MaharioContract SpecialistPRIMARY

Files

Files

Download
Download

Versions

Version 2Viewing
Solicitation
Posted: Mar 16, 2026
Version 1
Pre-Solicitation
Posted: Mar 5, 2026
View
6505--Famciclovir Tablets | GovScope